Clinical trial
Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
NCT04806620 is registered in ClinicalTrials.gov with Brain Inflammation Collaborative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
- Lead sponsor
- Brain Inflammation Collaborative
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 5, 2023
- Completion date
- December 31, 2030
- Enrollment
- 10,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis (as), anorexia nervosa, arfid, autoimmune diseases, autoimmune encephalitis, avoidant / restrictive food intake disorder, bulimia nervosa, celiac disease, celiac disease in children, chronic lyme disease, crohn's disease, dysautonomia, ehlers danlos syndrome, endometriosis, fibromyalgia (fm), general anxiety disorder, social anxiety disorder, inflammatory bowel disease (ibd), juvenile rheumatoid arthritis (jra), long covid, lupus, mast cell activation syndrome, me/cfs, migraines, multiple sclerosis, myalgic encephalomyelitis (me), myasthenia gravis in children, myasthenia gravis, generalized, narcolepsy, neurological diseases or conditions, obsessive compulsive disorder (ocd), pandas, pediatric acute-onset neuropsychiatric syndrome (pans), post-acute covid-19 syndrome, post-treatment lyme disease syndrome, pots - postural orthostatic tachycardia syndrome, psoriasis, psoriatic arthritis (psa), psychiatric disorder, ptsd - post traumatic stress disorder, rheumatic arthritis, sjogren's syndrome, tourette's syndrome, traumatic brain injury, ulcerative colitis and crohn's disease